Novocure Ltd - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NVCR Nasdaq 2836 https://www.novocure.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Novocure Ltd

Best Growth Stock in May - May 14th, 2018 10:02 am
Edited Transcript of NVCR earnings conference call or presentation 26-Apr-18 12:00pm GMT - May 11th, 2018 9:46 am
This Explains Why NovoCure Is Surging Today - Apr 26th, 2018 2:53 pm
NovoCure: 1Q Earnings Snapshot - Apr 26th, 2018 9:55 am
Novocure Ltd. to Host Earnings Call - Apr 26th, 2018 4:00 am
Novocure Reports First Quarter 2018 Financial Results and Provides Company Update - Apr 26th, 2018 4:00 am
NovoCure (NVCR) Shares March Higher, Can It Continue - Apr 25th, 2018 9:10 am
Analysis: Positioning to Benefit within Verastem, DineEquity, Olin, Quantum, Kimco Realty, and NovoCure — Research Highlights Growth, Revenue, and Consolidated Results - Apr 19th, 2018 6:00 am
Blog Exposure - NovoCure Announced Positive Top-line Results from STELLAR Trial Assessing TTFields in Mesothelioma - Apr 19th, 2018 5:10 am
NovoCure Limited (NVCR) Looks Good: Stock Adds 7.9% in Session - Apr 18th, 2018 6:31 am
Novocure Reports Positive Top-line Results from STELLAR Phase 2 Pilot Trial in Mesothelioma - Apr 17th, 2018 5:30 am
3 Top Healthcare Stocks to Buy in April - Apr 13th, 2018 4:31 pm
Data on Tumor Treating Fields to Be Presented at American Association for Cancer Research Annual Meeting - Apr 13th, 2018 2:30 pm
Is NovoCure Limited’s (NASDAQ:NVCR) Balance Sheet A Threat To Its Future? - Apr 3rd, 2018 10:23 am
Novocure to Report First Quarter 2018 Financial Results - Apr 3rd, 2018 5:30 am
NCCN Guidelines Recommend Optune in Combination with Temozolomide as a Category 1 Treatment for Newly Diagnosed Glioblastoma - Mar 20th, 2018 7:14 am
Wired News – NovoCure Announced Data Presentations on Tumor Treating Fields at AACR Annual Meeting 2018 - Mar 19th, 2018 5:00 am
Analysts Expect Breakeven For NovoCure Limited (NASDAQ:NVCR) - Mar 15th, 2018 3:42 pm
Novocure Announces 35 Presentations on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2018 - Mar 15th, 2018 5:30 am
Edited Transcript of NVCR earnings conference call or presentation 22-Feb-18 1:00pm GMT - Mar 8th, 2018 2:21 pm